Current Drug Delivery

ISSN: 1567-2018 - Volume 5, 4 Issues, 2008

Editor-in-Chief:

Istvan Toth
School of Pharmacy
University of Queensland
Brisbane 4072
Australia
Tel: office +61 7- 3365-1386 lab 3365- 7107
Fax: +61 7-3365-1688
E-mail: i.toth@uq.edu.au

Assistant Editor:

J. Blanchfield
School of Molecular and Microbial Sciences
University of Queensland
Australia
E-mail: j.blanchfield@uq.edu.au

Associate Editor:

Jay S. Trivedi
Patrin Pharma, Inc.
7817 Babb Avenue, Suite 103
Skokie, IL 60077
USA
E-mail: tjs@patrinpharma.com

Editorial Advisory Board:

A. Agrawal (DyoDelta Biosciences Ltd., London, UK)
S. Akhtar (Cardiff University, Cardiff, UK)
H.O.Alpar (University of London, London, UK)
P. Artursson (Biomedical Centre, Uppsala, Sweden)
H.A.E. Benson (Curtin University of Technology, Perth, Australia)
R. Borchardt (The University of Kansas, Lawrence, KS, USA)
S. Brocchini (University of London, London, UK)
S. A. Charman (Monash University, Parkville, Victoria, Australia)
S.T. Chen (Institute of Biological Chemistry, Taipei, Taiwan)
R. Duncan (Cardiff University, Cardiff. UK)
K. L. M. Edsman (Department of Pharmacy, Uppsala, Sweden)
V. Ferro (University of Strathclyde, Glasgow, UK)
A.T. Florence (University of London, London, UK)
M. Foldvari (University of Saskatchewan, Saskatoon, SK, Canada)
I. Gonda (Acrux Limited, West Melbourne, VIC, Australia)
F. Hudecz (Hungarian Academy of Sciences, Budapest, Hungary)
H. Ichikawa (Kobe Gakuin University, Kobe, Japan)
T. Inazu (Tokai University, Kanagawa, Japan)
D.S. Jones (Queen's University of Belfast, Belfast, UK)
H.E. Junginger (Leiden University, Leiden, The Netherlands)
B. Kellam (University of Nottingham, Nottingham, UK)
Michal Lebl (Illumina, Inc., San Diego, CA, USA)
J. Kopeck (University of Utah, Salt Lake City, USA)
P. Mascagni (Italfarmaco SpA, Milan, Italy)
R. New (Proxima Concepts Limited, London, UK)
Y. Okada (Kobe Gakuin University, Kobe, Japan)
L. Otvos (The Wistar Institute, Philadelphia, USA)
R. Panchagnula ( NIPER, Punjab, India)
A. M. Papini (University of Florence, Firenze, Italy)
R. Polt (University of Arizona, Tucson, AZ, USA)
F. Peri (University of Milano, Milano, Italy)
L. Prokai (University of North Texas Health Science Center, TX, USA)
M. Roberts (Univ. of Queensland, Princess Alexandra Hospital, Queensland, Australia)
S. Roffler (Institute of Biomedical Sciences, Taipei, Taiwan)
P. Rovero (Universita' di Firenze, Firenze, Italy)
M. Singh (Chiron Corp., Emeryville, CA, USA)
A. Somogyi (University of Adelaide, Adelaide, Australia)
Y.S. Tanwar (Bhupal Nobles' College of Pharmacy, Rajasthan, India)
H.C. Lutz F. Tietze (Uni. of Goettingen TammannstraBe, Goettingen, Germany)
V. Torchilin (Northeastern University, MA, USA)
I.F. Uchegbu (University of Strathclyde, Glasgow, UK)
A. Williams (University of Bradford, Bradford, West Yorkshire, UK)
K.-H. Weismuller (EMC Microcollections GmbH, Tubingen, Germany)